Table 1.
Pretransplant donor and tumour characteristics
|
|
No. (%)
|
| Donor age (/years) | |
| Median (Min.-Max.) | 54 (12-83) |
| Donor sex | |
| Male | 146 (62.4) |
| Female | 88 (37.6) |
| Donor type | |
| DBD | 126 (53.8) |
| DCD | 108 (46.2) |
| Tumour largest size (cm) | |
| ≤ 5 | 226 (98.3) |
| > 5 | 4 (1.7) |
| Median (range) | 2.4 (1-6.7) |
| Number of tumours | |
| ≤ 3 | 225 (97) |
| > 3 | 7 (3) |
| Median | 1 (1-6) |
| AFP-listing | |
| < 100 | 205 (88.8) |
| 100-500 | 21 (9) |
| 500-1000 | 1 (0.4) |
| > 1000 | 4 (1.7) |
| Median (range) | 7 (1-2634) |
| TACE | 93 (39.7) |
| Ablation | 57 (24.4) |
| MELD | |
| Median (range) | 9 (4-24) |
| UKELD | |
| Median (range) | 49 (41-65) |
AFP: Alpha fetoprotein; DCD: Donation after circulatory death; DBD: Donation after brain stem death; TACE: Transarterial chemoembolization; MELD: Model for End-Stage Liver Disease; UKELD: United Kingdom Model for End-Stage Liver Disease.